Commodore Capital LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $998 Million distributed in 31 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Merus N.V. with a value of $163M, Vaxcyte, Inc. with a value of $133M, Nuvalent, Inc. with a value of $127M, Xenon Pharmaceuticals Inc. with a value of $107M, and Vera Therapeutics, Inc. with a value of $82.8M.
Examining the 13F form we can see an decrease of $179M in the current position value, from $1.18B to 998M.
Commodore Capital LP is based out at New York, NY
Below you can find more details about Commodore Capital LP portfolio as well as his latest detailed transactions.
